Sina Technology learned from JD Health that in the first half of 2026, JD Health launched a total of 65 new drugs, covering the fields of oncology, skin, chronic diseases, etc., leading the industry for many years in a row in the number of new drug launches. Throughout 2025, JD Health's total revenue reached 73.4 billion yuan, a year-on-year increase of 26.3%, and annual active users reached 218 million. The scale of pharmaceutical retail continued to lead the industry. This scale advantage has enabled JD Health to establish a service network with the longest life cycle and the widest coverage for service users, and to form a “medical examination and drug diagnosis” full-link closed-loop capability unique in the industry. Currently, the JD Health Service Network has covered millions of natural villages across the country.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.